Karthik Kuppusamy - 21 Apr 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role: SVP, Clinical Solutions
Signature: Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy
Issuer symbol: DGX
Transactions as of: 21 Apr 2025
Net transactions value: +$4,439
Form type: 4
Filing time: 02 May 2025, 16:32:51 UTC
Previous filing: 04 Apr 2025
Next filing: 25 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS	Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy	02 May 2025	0001955217

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DGX	Common Stock	Small acquisition under Rule 16a-6	$4,439	+27	+0.26%	$164.42	10,612	21 Apr 2025	Direct	F1
holding	DGX	Common Stock						358	21 Apr 2025	By Trust
holding	DGX	Common Stock						1,620	21 Apr 2025	401(k)	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
F2	These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Content

Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.